Demonstrating clinical benefit is the ultimate gateway to smoother patient access. When health plan and pharmacy benefit manager (PBM) clinical decision-makers review a Phase II or Phase III product ...
Full results published in the New England Journal of Medicine and presented at ATS 2025 International Conference BATURA builds upon the previous Phase III MANDALA and DENALI trials and in totality, ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する